CN102036557A - 烷基化剂的稳定组合物及其使用方法 - Google Patents
烷基化剂的稳定组合物及其使用方法 Download PDFInfo
- Publication number
- CN102036557A CN102036557A CN2009801186378A CN200980118637A CN102036557A CN 102036557 A CN102036557 A CN 102036557A CN 2009801186378 A CN2009801186378 A CN 2009801186378A CN 200980118637 A CN200980118637 A CN 200980118637A CN 102036557 A CN102036557 A CN 102036557A
- Authority
- CN
- China
- Prior art keywords
- mustargen
- weight
- pharmaceutically acceptable
- alkylating agent
- ethanol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 *C(C=NC(N1)=O)C1=C Chemical compound *C(C=NC(N1)=O)C1=C 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/131—Amines acyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims (22)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710563914.2A CN107149591A (zh) | 2008-03-27 | 2009-03-11 | 烷基化剂的稳定组合物及其使用方法 |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3984008P | 2008-03-27 | 2008-03-27 | |
US61/039,840 | 2008-03-27 | ||
PCT/US2009/036737 WO2009120493A2 (en) | 2008-03-27 | 2009-03-11 | Stabilized compositions of alkylating agents and methods of using same |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710563914.2A Division CN107149591A (zh) | 2008-03-27 | 2009-03-11 | 烷基化剂的稳定组合物及其使用方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN102036557A true CN102036557A (zh) | 2011-04-27 |
Family
ID=41114573
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2009801186378A Pending CN102036557A (zh) | 2008-03-27 | 2009-03-11 | 烷基化剂的稳定组合物及其使用方法 |
CN201710563914.2A Pending CN107149591A (zh) | 2008-03-27 | 2009-03-11 | 烷基化剂的稳定组合物及其使用方法 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710563914.2A Pending CN107149591A (zh) | 2008-03-27 | 2009-03-11 | 烷基化剂的稳定组合物及其使用方法 |
Country Status (14)
Country | Link |
---|---|
US (2) | US8501817B2 (zh) |
EP (2) | EP2273876B1 (zh) |
CN (2) | CN102036557A (zh) |
CY (2) | CY1121777T1 (zh) |
DK (1) | DK3494960T3 (zh) |
ES (2) | ES2848841T3 (zh) |
HR (2) | HRP20190551T1 (zh) |
HU (2) | HUE053482T2 (zh) |
LT (2) | LT3494960T (zh) |
PL (2) | PL3494960T3 (zh) |
PT (2) | PT3494960T (zh) |
SI (2) | SI3494960T1 (zh) |
TR (1) | TR201907794T4 (zh) |
WO (1) | WO2009120493A2 (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8501818B2 (en) * | 2005-03-14 | 2013-08-06 | Ceptaris Therapeutics, Inc. | Stabilized compositions of alkylating agents and methods of using same |
US7872050B2 (en) | 2005-03-14 | 2011-01-18 | Yaupon Therapeutics Inc. | Stabilized compositions of volatile alkylating agents and methods of using thereof |
US20110039943A1 (en) * | 2005-03-14 | 2011-02-17 | Robert Alonso | Methods for treating skin disorders with topical nitrogen mustard compositions |
SI3494960T1 (sl) * | 2008-03-27 | 2021-04-30 | Helsinn Healthcare Sa | Stabilizirani sestavki alkilirajočih sredstev in metode uporabe le-teh |
US20180125797A1 (en) * | 2016-11-07 | 2018-05-10 | Actelion Pharmaceuticals Ltd | Methods for treating skin disorders with a topical composition of bis-(2-chloroethyl)methylamine |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060205694A1 (en) * | 2005-03-14 | 2006-09-14 | Robert Alonso | Stabilized compositions of volatile alkylating agents and methods of using thereof |
US20070287719A1 (en) * | 2005-03-11 | 2007-12-13 | Pfizer Inc | Salts, Prodrugs and Formulations of 1-[5-(4-Amino-7-Isopropyl-7H-Pyrrolo[2,3-D]Pyrimidine-5-Carbonyl)-2-Methoxy-Phenyl]-3-(2,4-Dichloro-Phenyl)-Urea |
Family Cites Families (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4083692A (en) | 1970-06-04 | 1978-04-11 | The United States Of America As Represented By The Secretary Of The Army | Detection and estimation of microquantities of alkylating agents |
US3767792A (en) | 1971-07-02 | 1973-10-23 | Stanley Drug Products Inc | Method for controlling the toxicity of drug products |
US3904766A (en) | 1973-06-19 | 1975-09-09 | Scott Eugene J Van | Treatment of psoriasis |
US4206222A (en) | 1977-06-23 | 1980-06-03 | Societe Civile Particuliere De Brevets Suffren | Method for preparing a substance having properties against collagen diseases and products obtained |
WO1987004154A1 (en) | 1986-01-03 | 1987-07-16 | The University Of Melbourne | Melphalan derivatives |
US4863910A (en) | 1986-05-20 | 1989-09-05 | Takeo Takayanagi | Complexes of AZO compounds and/or their salts and an antitumor agent and a method for reducing the growth of tumors |
US4725438A (en) | 1986-05-29 | 1988-02-16 | Leazer Billie S | Aloe vera ointment |
IE60588B1 (en) | 1986-07-30 | 1994-07-27 | Sumitomo Pharma | Carbapenem compound in crystalline form, and its production and use |
US5326790A (en) | 1986-11-19 | 1994-07-05 | Dermatologic Research Corporation | Administration of skin medications by use of dicarboxylic acids and derivatives |
US4853388A (en) | 1987-05-15 | 1989-08-01 | Pearlman Dale L | Method for treating psoriasis with cytotoxic agents |
US5051363A (en) | 1987-06-26 | 1991-09-24 | University Of Pennsylvania | Method for modifying the toxicity of DNA reactive cross-linking agents to cells |
US5229422A (en) | 1987-09-07 | 1993-07-20 | Teijin Limited | Extemporaneous preparation type kit of a pharmaceutical substance-containing fat emulsion |
GB8727157D0 (en) | 1987-11-19 | 1987-12-23 | Wellcome Found | Pharmaceutical formulations |
US4888354A (en) | 1987-12-21 | 1989-12-19 | Theratech, Inc. | Skin penetration enhancement using free base and acid addition salt combinations of active agents |
US5719197A (en) | 1988-03-04 | 1998-02-17 | Noven Pharmaceuticals, Inc. | Compositions and methods for topical administration of pharmaceutically active agents |
US4949641A (en) | 1990-03-05 | 1990-08-21 | The United States Of America As Represented By The Secretary Of The Army | Method of safely detoxifying mustard gases |
US6764681B2 (en) | 1991-10-07 | 2004-07-20 | Biogen, Inc. | Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the CD2/LFA-3 interaction |
US5820872A (en) | 1992-11-18 | 1998-10-13 | Yale University | Methods and compositions for improving the effectiveness of X-irradiation therapy for the treatment of an internal solid tumor |
WO1995003028A1 (en) | 1993-07-23 | 1995-02-02 | Morris Herstein | Cosmetic, skin-renewal stimulating composition with long-term irritation control |
FR2728166A1 (fr) | 1994-12-19 | 1996-06-21 | Oreal | Composition topique contenant un antagoniste de substance p |
GB9501052D0 (en) | 1995-01-19 | 1995-03-08 | Cancer Res Campaign Tech | Improvements relating to prodrugs |
US6551611B2 (en) | 1995-09-28 | 2003-04-22 | Schering Aktiengesellschaft | Hormone replacement therapy method |
US5744460A (en) * | 1996-03-07 | 1998-04-28 | Novartis Corporation | Combination for treatment of proliferative diseases |
US6124108A (en) | 1996-05-15 | 2000-09-26 | The United States Of America As Represented By The Secretary Of The Army | Protein biomarker for mustard chemical injury |
US5948437A (en) * | 1996-05-23 | 1999-09-07 | Zeneca Limited | Pharmaceutical compositions using thiazepine |
AU3276297A (en) | 1996-06-27 | 1998-01-14 | Chugai Seiyaku Kabushiki Kaisha | Remedies for myeloma to be used together with nitrogen mustard antitumor agents |
CA2257860A1 (en) | 1996-07-11 | 1998-01-22 | Farmarc Nederland B.V. | Inclusion complex containing indole selective serotonin agonist |
US6753155B1 (en) | 1997-05-13 | 2004-06-22 | The United States Of America As Represented By The Secretary Of The Army | Protein biomarker for mustard chemical injury |
AU8282798A (en) | 1997-07-01 | 1999-01-25 | Atherogenics, Inc. | Antioxidant enhancement of therapy for hyperproliferative conditions |
CA2318811A1 (en) * | 1998-01-30 | 1999-08-26 | Cold Spring Harbor Laboratory | Modulation of cell proliferation, methods and reagents |
GB9805868D0 (en) | 1998-03-20 | 1998-05-13 | Zeneca Ltd | Anti-tumour agents |
US6399678B2 (en) * | 1998-06-25 | 2002-06-04 | Tamko Roofing Products | Silicone-aggregate mixtures for pumping and spraying applications |
US20060079492A1 (en) * | 1999-10-25 | 2006-04-13 | Ahlem Clarence N | Compositions and treatment methods |
US6329148B1 (en) | 1999-02-16 | 2001-12-11 | The Board Of Trustees Of The Leland Stanford University | Combined therapy of diterpenoid triepoxides and death domain receptor ligands for synergistic killing of tumor cells |
US6017902A (en) | 1999-02-25 | 2000-01-25 | Brookhaven Science Associates | Boron containing amino acid compounds and methods for their use |
US20020146692A1 (en) | 2000-01-21 | 2002-10-10 | Victoria Yamazaki | Methods and materials relating to G protein-coupled receptor-like polypeptides and polynucleotides |
US7198801B2 (en) * | 2000-08-03 | 2007-04-03 | Antares Pharma Ipl Ag | Formulations for transdermal or transmucosal application |
US20030215471A1 (en) * | 2001-01-31 | 2003-11-20 | Wilmott James M. | Surfactant free topical compositions and method for rapid preparation thereof |
US7547673B2 (en) | 2001-09-13 | 2009-06-16 | The Johns Hopkins University | Therapeutics for cancer using 3-bromopyruvate and other selective inhibitors of ATP production |
IL161057A0 (en) | 2001-09-25 | 2004-08-31 | Quick Med Technologies Inc | Composition and method for minimizing or avoiding adverse effects of vesicants |
US20030082229A1 (en) | 2001-11-01 | 2003-05-01 | Board Of Regents, The University Of Texas Systems | Parenteral chlorambucil for treatment of malignant and autoimmune disease and methods of use |
JP4854198B2 (ja) * | 2002-11-12 | 2012-01-18 | ジューイッシュ・ジェネラル・ホスピタル | 慢性リンパ性白血病の処置のためのナイトロジェンマスタードアナログとイマチニブの組み合わせ剤 |
WO2004050057A2 (en) | 2002-12-04 | 2004-06-17 | Technologies Biolactis Inc. | An exopolysaccharides delivery system for active molecules |
WO2004113573A2 (en) | 2003-06-19 | 2004-12-29 | The Samuel Roberts Noble Foundation, Inc. | Methods and compositions for analysis of plant gene function |
WO2005007129A2 (en) | 2003-07-17 | 2005-01-27 | Angiotech International Ag | Topical formulations with bioactive components |
US20110039943A1 (en) | 2005-03-14 | 2011-02-17 | Robert Alonso | Methods for treating skin disorders with topical nitrogen mustard compositions |
US20060281720A1 (en) | 2005-06-08 | 2006-12-14 | Loria Roger M | 5-Androstenediol As An Inhibitor of Gliomas |
SI3494960T1 (sl) | 2008-03-27 | 2021-04-30 | Helsinn Healthcare Sa | Stabilizirani sestavki alkilirajočih sredstev in metode uporabe le-teh |
-
2009
- 2009-03-11 SI SI200932113T patent/SI3494960T1/sl unknown
- 2009-03-11 DK DK18214529.2T patent/DK3494960T3/da active
- 2009-03-11 CN CN2009801186378A patent/CN102036557A/zh active Pending
- 2009-03-11 EP EP09724939.5A patent/EP2273876B1/en active Active
- 2009-03-11 ES ES18214529T patent/ES2848841T3/es active Active
- 2009-03-11 LT LTEP18214529.2T patent/LT3494960T/lt unknown
- 2009-03-11 HU HUE18214529A patent/HUE053482T2/hu unknown
- 2009-03-11 EP EP18214529.2A patent/EP3494960B1/en active Active
- 2009-03-11 SI SI200931973T patent/SI2273876T1/sl unknown
- 2009-03-11 PT PT182145292T patent/PT3494960T/pt unknown
- 2009-03-11 ES ES09724939T patent/ES2727523T3/es active Active
- 2009-03-11 HU HUE09724939A patent/HUE043767T2/hu unknown
- 2009-03-11 WO PCT/US2009/036737 patent/WO2009120493A2/en active Application Filing
- 2009-03-11 PT PT09724939T patent/PT2273876T/pt unknown
- 2009-03-11 PL PL18214529T patent/PL3494960T3/pl unknown
- 2009-03-11 PL PL09724939T patent/PL2273876T3/pl unknown
- 2009-03-11 LT LTEP09724939.5T patent/LT2273876T/lt unknown
- 2009-03-11 CN CN201710563914.2A patent/CN107149591A/zh active Pending
- 2009-03-11 TR TR2019/07794T patent/TR201907794T4/tr unknown
- 2009-03-11 US US12/401,812 patent/US8501817B2/en active Active
-
2013
- 2013-06-06 US US13/911,217 patent/US20140142193A1/en not_active Abandoned
-
2019
- 2019-03-21 HR HRP20190551TT patent/HRP20190551T1/hr unknown
- 2019-05-24 CY CY20191100556T patent/CY1121777T1/el unknown
-
2021
- 2021-02-08 CY CY20211100102T patent/CY1123974T1/el unknown
- 2021-02-18 HR HRP20210283TT patent/HRP20210283T1/hr unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070287719A1 (en) * | 2005-03-11 | 2007-12-13 | Pfizer Inc | Salts, Prodrugs and Formulations of 1-[5-(4-Amino-7-Isopropyl-7H-Pyrrolo[2,3-D]Pyrimidine-5-Carbonyl)-2-Methoxy-Phenyl]-3-(2,4-Dichloro-Phenyl)-Urea |
US20060205694A1 (en) * | 2005-03-14 | 2006-09-14 | Robert Alonso | Stabilized compositions of volatile alkylating agents and methods of using thereof |
Also Published As
Publication number | Publication date |
---|---|
TR201907794T4 (tr) | 2019-06-21 |
HRP20210283T1 (hr) | 2021-04-02 |
PT2273876T (pt) | 2019-06-04 |
EP2273876A2 (en) | 2011-01-19 |
WO2009120493A3 (en) | 2010-03-04 |
EP2273876B1 (en) | 2019-03-06 |
EP3494960A1 (en) | 2019-06-12 |
US8501817B2 (en) | 2013-08-06 |
HUE043767T2 (hu) | 2019-09-30 |
HRP20190551T1 (hr) | 2019-05-03 |
SI3494960T1 (sl) | 2021-04-30 |
EP3494960B1 (en) | 2020-11-25 |
US20140142193A1 (en) | 2014-05-22 |
LT2273876T (lt) | 2019-05-27 |
DK3494960T3 (da) | 2021-01-25 |
EP2273876A4 (en) | 2013-10-23 |
ES2848841T3 (es) | 2021-08-12 |
ES2727523T3 (es) | 2019-10-16 |
HUE053482T2 (hu) | 2021-06-28 |
PL3494960T3 (pl) | 2021-05-17 |
SI2273876T1 (sl) | 2019-09-30 |
US20090247645A1 (en) | 2009-10-01 |
PT3494960T (pt) | 2021-02-09 |
PL2273876T3 (pl) | 2019-09-30 |
CY1121777T1 (el) | 2020-07-31 |
WO2009120493A2 (en) | 2009-10-01 |
CY1123974T1 (el) | 2022-05-27 |
LT3494960T (lt) | 2021-02-25 |
CN107149591A (zh) | 2017-09-12 |
US20100029783A9 (en) | 2010-02-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101175735B (zh) | 挥发性烷基化剂的稳定组合物及其使用方法 | |
CN102036557A (zh) | 烷基化剂的稳定组合物及其使用方法 | |
US20140187810A1 (en) | Stabilized compositions of alkylating agents and methods of using same | |
US20110039943A1 (en) | Methods for treating skin disorders with topical nitrogen mustard compositions | |
US20120157545A1 (en) | Methods for treating skin disorders with topical nitrogen mustard compositions | |
AU2012202164A1 (en) | Stabilized compositions of volatile alkylating agents and methods of using thereof | |
AU2015201458A1 (en) | Stabilized compositions of volatile alkylating agents and methods of using thereof | |
Tang | i, United States Patent (10) Patent No.: US 8,450.375 B2 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent of invention or patent application | ||
CB02 | Change of applicant information |
Address after: American Pennsylvania Applicant after: Sepatec Reyes Medical Co. Ltd. Address before: American Pennsylvania Applicant before: Yaupon Therapeutics Inc. |
|
COR | Change of bibliographic data |
Free format text: CORRECT: APPLICANT; FROM: YAUPON THERAPEUTICS INC. TO: SEPTERIS MEDICAL CO., LTD. |
|
ASS | Succession or assignment of patent right |
Owner name: ACTELION PHARMACEUTICALS LTD. Free format text: FORMER OWNER: SEPTERIS MEDICAL CO., LTD. Effective date: 20140102 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20140102 Address after: Swiss Bonneville Applicant after: Actelion Pharmaceuticals Ltd. Address before: American Pennsylvania Applicant before: Sepatec Reyes Medical Co. Ltd. |
|
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20110427 Assignee: Sepatec Reyes Medical Co. Ltd. Assignor: Actelion Pharmaceuticals Ltd. Contract record no.: 2014990000108 Denomination of invention: Stabilized compositions of volatile alkylating agents and methods of using thereof License type: Exclusive License Record date: 20140306 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
EC01 | Cancellation of recordation of patent licensing contract |
Assignee: Sepatec Reyes Medical Co. Ltd. Assignor: Actelion Pharmaceuticals Ltd. Contract record no.: 2014990000108 Date of cancellation: 20150306 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20110427 |